September 2017
How the Rich Invest: Andrew Forrest
Andrew Forrest's latest big investment is rugby union.
- Updated
- John Stensholt
November 2016
How the Rich Invest: Andrew Forrest bulks up Fortescue holding
The value of Andrew Forrest's Fortescue holding has climbed by $3.8 billion this year but his other stocks are lagging.
- Updated
- John Stensholt
February 2014
Twiggy’s biotech gets US tick for cardiac treatment
Admedus, which counts mining magnate Andrew Forrest as a cornerstone investor, has passed an important milestone the US approving its regenerative tissue treatment for heart defects.
- Updated
- Jessica Gardner
March 2012
Kai Medical tests waters for IPO
Appetite for initial public offerings may not be particularly healthy, but that has not stopped JPMorgan testing investor interest in a float of medical device company Kai Medical.
- Updated
- Sarah Thompson and Anthony Macdonald
February 2012
Biotechs making a steady recovery
There is likely to be a sharp pick-up in interest in Australian biotechs this year as they move into their next phase of growth, which will pave the way for them to be taken over by global drug companies.
- Updated
- Brendon Lau
October 2011
Allied Healthcare (AHZ)
Allied Healthcare has secured a $5 million equity funding package to pay for subsidiary Coridon’s vaccine development program and launch its CardioCel product.
- Updated
- Anna Raissis